BI Asset Management Fondsmaeglerselskab A S Lowers Stock Holdings in HCA Healthcare, Inc. $HCA

BI Asset Management Fondsmaeglerselskab A S cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 20.3% during the 1st quarter, Holdings Channel.com reports. The firm owned 71,998 shares of the company’s stock after selling 18,379 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in HCA Healthcare were worth $34,072,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of HCA. Nordea Investment Management AB lifted its holdings in shares of HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after acquiring an additional 108,849 shares during the last quarter. Nomura Asset Management Co. Ltd. raised its position in HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after purchasing an additional 3,724 shares during the period. Hudson Bay Capital Management LP boosted its position in HCA Healthcare by 154.5% during the third quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock valued at $2,000,000 after buying an additional 2,849 shares during the period. Advisors Capital Management LLC increased its holdings in shares of HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after buying an additional 2,604 shares during the period. Finally, CWA Asset Management Group LLC boosted its holdings in HCA Healthcare by 1,062.4% during the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock valued at $4,461,000 after acquiring an additional 8,733 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $375.37 on Friday. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The firm has a market capitalization of $83.27 billion, a P/E ratio of 12.91, a P/E/G ratio of 1.19 and a beta of 1.12. The stock has a 50 day moving average price of $419.68 and a 200-day moving average price of $469.05.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on HCA shares. Mizuho lifted their price target on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. Wells Fargo & Company decreased their target price on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research note on Monday, April 27th. Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. TD Cowen decreased their price objective on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, April 27th. Finally, Leerink Partners cut their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.